PURPOSE: Euterpe oleracea Mart. (açaí) seed extract (ASE), through its anti-hypertensive, antioxidant and anti-inflammatory properties, may be useful to treat or prevent human diseases. Several evidences suggest that oxidative stress and inflammation contribute to the pathogenesis of diabetic nephropathy; therefore, we tested the hypothesis that ASE (200 mg/kg-1day-1) prevents diabetes and hypertension-related oxidative stress and inflammation, attenuating renal injury. METHODS: Male rats with streptozotocin (STZ)-induced diabetes (D), and spontaneously hypertensive rats with STZ-induced diabetes (DH) were treated daily with tap water or ASE (D + ASE and DH + ASE, respectively) for 45 days. The control (C) and hypertensive (H) animals received water. RESULTS: The elevated serum levels of urea and creatinine in D and DH, and increased albumin excretion in HD were reduced by ASE. Total glomeruli number in D and DH, were increased by ASE that also reduced renal fibrosis in both groups by decreasing collagen IV and TGF-β1 expression. ASE improved biomarkers of renal filtration barrier (podocin and nephrin) in D and DH groups and prevented the increased expression of caspase-3, IL-6, TNF-α and MCP-1 in both groups. ASE reduced oxidative damage markers (TBARS, carbonyl levels and 8-isoprostane) in D and DH associated with a decrease in Nox 4 and p47 subunit expression and increase in antioxidant enzyme activity in both groups (SOD, catalase and GPx). CONCLUSION: ASE substantially reduced renal injury and prevented renal dysfunction by reducing inflammation, oxidative stress and improving the renal filtration barrier, providing a nutritional resource for prevention of diabetic and hypertensive-related nephropathy.
PURPOSE:Euterpe oleracea Mart. (açaí) seed extract (ASE), through its anti-hypertensive, antioxidant and anti-inflammatory properties, may be useful to treat or prevent human diseases. Several evidences suggest that oxidative stress and inflammation contribute to the pathogenesis of diabetic nephropathy; therefore, we tested the hypothesis that ASE (200 mg/kg-1day-1) prevents diabetes and hypertension-related oxidative stress and inflammation, attenuating renal injury. METHODS: Male rats with streptozotocin (STZ)-induced diabetes (D), and spontaneously hypertensiverats with STZ-induced diabetes (DH) were treated daily with tap water or ASE (D + ASE and DH + ASE, respectively) for 45 days. The control (C) and hypertensive (H) animals received water. RESULTS: The elevated serum levels of urea and creatinine in D and DH, and increased albumin excretion in HD were reduced by ASE. Total glomeruli number in D and DH, were increased by ASE that also reduced renal fibrosis in both groups by decreasing collagen IV and TGF-β1 expression. ASE improved biomarkers of renal filtration barrier (podocin and nephrin) in D and DH groups and prevented the increased expression of caspase-3, IL-6, TNF-α and MCP-1 in both groups. ASE reduced oxidative damage markers (TBARS, carbonyl levels and 8-isoprostane) in D and DH associated with a decrease in Nox 4 and p47 subunit expression and increase in antioxidant enzyme activity in both groups (SOD, catalase and GPx). CONCLUSION:ASE substantially reduced renal injury and prevented renal dysfunction by reducing inflammation, oxidative stress and improving the renal filtration barrier, providing a nutritional resource for prevention of diabetic and hypertensive-related nephropathy.
Authors: Bruno S Pessôa; Elisa B M I Peixoto; Alexandros Papadimitriou; Jacqueline M Lopes de Faria; José B Lopes de Faria Journal: J Renin Angiotensin Aldosterone Syst Date: 2011-10-10 Impact factor: 1.636
Authors: Roberto Soares de Moura; Karla Maria Pereira Pires; Thiago Santos Ferreira; Alan Aguiar Lopes; Renata Tiscoski Nesi; Angela Castro Resende; Pergentino Jose Cunha Sousa; Antonio Jorge Ribeiro da Silva; Luis Cristóvão Porto; Samuel Santos Valenca Journal: Food Chem Toxicol Date: 2010-12-13 Impact factor: 6.023
Authors: Omotayo O Erejuwa; Siti A Sulaiman; Mohd Suhaimi Ab Wahab; Kuttulebbai N S Sirajudeen; Md Salzihan Md Salleh; Sunil Gurtu Journal: Int J Mol Sci Date: 2011-03-16 Impact factor: 5.923
Authors: Paola Raquel B de Oliveira; Cristiane A da Costa; Graziele F de Bem; Viviane S C Cordeiro; Izabelle B Santos; Lenize C R M de Carvalho; Ellen Paula S da Conceição; Patrícia Cristina Lisboa; Dayane T Ognibene; Pergentino José C Sousa; Gabriel R Martins; Antônio Jorge R da Silva; Roberto S de Moura; Angela C Resende Journal: PLoS One Date: 2015-12-02 Impact factor: 3.240
Authors: Isabelle C V S Martins; Natália A Borges; Peter Stenvinkel; Bengt Lindholm; Hervé Rogez; Maria C N Pinheiro; José L M Nascimento; Denise Mafra Journal: Int Urol Nephrol Date: 2018-06-18 Impact factor: 2.370
Authors: D Canistro; F Vivarelli; S Cirillo; A Soleti; B Albertini; N Passerini; G Merizzi; M Paolini Journal: J Endocrinol Invest Date: 2018-03-06 Impact factor: 4.256
Authors: Graziele Freitas de Bem; Cristiane Aguiar Costa; Izabelle Barcellos Santos; Viviane da Silva Cristino Cordeiro; Lenize Costa Reis Marins de Carvalho; Marcelo Augusto Vieira de Souza; Ricardo de Andrade Soares; Pergentino José da Cunha Sousa; Dayane Teixeira Ognibene; Angela Castro Resende; Roberto Soares de Moura Journal: PLoS One Date: 2018-06-19 Impact factor: 3.240
Authors: José Rogério Souza-Monteiro; Gabriela P F Arrifano; Ana Isabelle D G Queiroz; Bruna S F Mello; Charllyany S Custódio; Danielle S Macêdo; Moisés Hamoy; Ricardo S O Paraense; Leonardo O Bittencourt; Rafael R Lima; Rommel R Burbano; Hervé Rogez; Cristiane F Maia; Barbarella M Macchi; José Luiz M do Nascimento; Maria Elena Crespo-López Journal: Oxid Med Cell Longev Date: 2019-07-24 Impact factor: 6.543
Authors: Alvaro Ferreira Monteiro; Ingrid Santos Miguez; João Pedro R Barros Silva; Ayla Sant'Ana da Silva Journal: Sci Rep Date: 2019-07-29 Impact factor: 4.379
Authors: Thalita Sévia Soares de Almeida Magalhães; Pollyana Cristina de Oliveira Macedo; Attilio Converti; Ádley Antonini Neves de Lima Journal: Biomolecules Date: 2020-05-26